{"date":"2025-01-18","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1707-2025-01-18-1701-4dgewb","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-01-18","time":"17:01:52","subject":"公告本公司董事會決議增加投資興建平鎮工業區廠房-第一期金額(更新111/02/23之重訊內容)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-01-18 17:01，「公告本公司董事會決議增加投資興建平鎮工業區廠房-第一期金額(更新111/02/23之重訊內容)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-01-18-1057-vdriq7","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-01-18","time":"10:57:49","subject":"代子公司Applied BioCode, Inc.公告所開發的17項腸胃道多元分子檢測套組(GPP)及自動化診斷系統(MDx 3000)，搭配賽默飛世爾KingFisher萃取儀器前處理系統，取得美國FDA上市許可。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-01-18 10:57，「代子公司Applied BioCode, Inc.公告所開發的17項腸胃道多元分子檢測套組(GPP)及自動化診斷系統(M」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}